The Clorox Company (NYSE:CLX) Shares Sold by Everence Capital Management Inc.

Everence Capital Management Inc. lowered its holdings in shares of The Clorox Company (NYSE:CLX) by 61.1% in the fourth quarter, Holdings Channel reports. The firm owned 1,690 shares of the company’s stock after selling 2,660 shares during the quarter. Everence Capital Management Inc.’s holdings in Clorox were worth $274,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Prospera Private Wealth LLC acquired a new stake in shares of Clorox during the third quarter worth about $27,000. Continuum Advisory LLC lifted its position in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the period. Trifecta Capital Advisors LLC grew its stake in shares of Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. Quarry LP increased its holdings in shares of Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC purchased a new stake in shares of Clorox during the third quarter worth approximately $48,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Up 1.4 %

NYSE:CLX opened at $159.76 on Wednesday. The company has a market capitalization of $19.78 billion, a PE ratio of 55.67, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The stock has a fifty day simple moving average of $164.64 and a 200-day simple moving average of $155.33. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm earned $0.49 earnings per share. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. On average, equities research analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.05%. Clorox’s dividend payout ratio (DPR) is 170.03%.

Analysts Set New Price Targets

Several brokerages have issued reports on CLX. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and boosted their price objective for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Evercore ISI cut their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Barclays lifted their price objective on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. JPMorgan Chase & Co. increased their target price on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. Finally, DA Davidson lifted their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $157.46.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.